prognost signific anticentromer antibodi anti-topoisomeras antibodi raynaud diseas prospect studi seventy-seven patient raynaud diseas mean year year relationship autoantibodi long-term clinic outcom anticentromer antibodi aca indirect immunofluoresc hela cell chromosom extract antibodi anti-topo immunodiffus immunoblot antibodi major centromer protein cenp-b anti-topo enzyme-link immunosorb assay elisa patient telangiectasia skin tighten connect tissu diseas scleroderma presenc aca start studi develop telangiectasia initi band immunoblot conjunct posit anti-topo elisa result develop tight skin band neg anti-topo elisa result subsequ develop connect tissu diseas scleroderma patient aca posit band immunoblot posit elisa result anti-topo anti-cenp-b like sign connect tissu diseas end studi presenc autoantibodi sensit specif find nailfold capillaroscopi sensit specif subsequ clinic progress find assay anti-topo aca find nailfold capillaroscopi use prognost inform raynaud diseas 